Gufic BioSciences share price
You have to be logged in to add this to Watchlist.- ₹287.20(0.77%)May 20, 2026 10:20:14 AM IST
- NSE
- BSE
- Vol : 5.62 K (NSE + BSE)Last 20 day avg : 67.06 K
Gufic BioSciences is trading 0.77% upper at Rs 287.20 as compared to its last closing price. Gufic BioSciences has been trading in the price range of 288.25 & 286.15. Gufic BioSciences has given -14.85% in this year & -3.49% in the last 5 days. Gufic BioSciences has TTM P/E ratio 67.36 as compared to the sector P/E of 25.16.The company posted a net profit of 12.42 Crores in its last quarter.Listed peers of Gufic BioSciences include Sun Pharmaceutical Industries (0.36%), Torrent Pharmaceuticals (0.39%), Divi's Laboratories (-0.03%).The Mutual Fund holding in Gufic BioSciences was at 3.63% in 31 Mar 2026. The MF holding has increased from the last quarter. The FII holding in Gufic BioSciences was at 0.42% in 31 Mar 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on May 20, 2026, 05:14 AM UTC
- BetaLow volatility0.61Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.56The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.04Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-5The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,888.90 | 0.36 | 4,53,163.59 | 37.11 | 5.91 | 0.93 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,474.75 | 0.39 | 1,51,439.79 | 74.30 | 18.87 | 0.83 | 17.62 |
| Divi's Laboratories | Bullish | 6,910.50 | -0.03 | 1,83,269.13 | 79.06 | 11.59 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Bullish | 1,327.90 | -0.45 | 1,10,828.92 | 19.57 | 3.3 | 0.60 | 2.34 |
| Cipla | Moderately Bullish | 1,417.70 | 0.56 | 1,14,503.10 | 20.21 | 3.41 | 0.99 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results & Others |
- IndustryBiotechnology & Drugs
- ISININE742B01025
- BSE Code509079
- NSE CodeGUFICBIO
Gufic BioSciences is trading at 287.20 as on Wed May 20 2026 04:50:14. This is 0.77% upper as compared to its previous closing price of 285.00.
The market capitalization of Gufic BioSciences is 2880.11 Cr as on Wed May 20 2026 04:50:14.
The 52 wk high for Gufic BioSciences is 409.00 whereas the 52 wk low is 267.50
Gufic BioSciences can be analyzed on the following key metrics -
- TTM P/E: 67.36
- Sector P/E: 25.16
- Dividend Yield: 0.03%
- D/E ratio: -
Gufic BioSciences reported a net profit of 69.65 Cr in 2025.
The Mutual Fund Shareholding was 3.63% at the end of 31 Mar 2026.
EQUITY QUICK LINKS
Gufic BioSciences QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.